IRIS
MAFFIOLI, PAMELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.371
AS - Asia 7.688
EU - Europa 5.477
SA - Sud America 1.184
Continente sconosciuto - Info sul continente non disponibili 350
AF - Africa 269
OC - Oceania 21
Totale 25.360
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.111
CN - Cina 3.933
SG - Singapore 1.649
IE - Irlanda 1.181
UA - Ucraina 936
BR - Brasile 893
DE - Germania 766
HK - Hong Kong 758
FI - Finlandia 676
VN - Vietnam 592
RU - Federazione Russa 520
IT - Italia 373
FR - Francia 333
SE - Svezia 270
GB - Regno Unito 225
ZA - Sudafrica 157
CA - Canada 151
BD - Bangladesh 141
IN - India 138
AR - Argentina 100
MX - Messico 58
IQ - Iraq 56
EC - Ecuador 54
TR - Turchia 52
JP - Giappone 51
ID - Indonesia 43
CO - Colombia 39
NL - Olanda 39
PK - Pakistan 34
ES - Italia 28
UZ - Uzbekistan 28
PH - Filippine 26
VE - Venezuela 25
PL - Polonia 22
MA - Marocco 21
MY - Malesia 21
JO - Giordania 20
PE - Perù 20
SA - Arabia Saudita 18
TN - Tunisia 18
IR - Iran 17
PY - Paraguay 17
CL - Cile 16
EG - Egitto 16
AL - Albania 13
IL - Israele 13
TH - Thailandia 13
BE - Belgio 12
BO - Bolivia 11
KE - Kenya 11
AT - Austria 10
KZ - Kazakistan 10
AU - Australia 9
BH - Bahrain 9
MU - Mauritius 9
RO - Romania 9
AZ - Azerbaigian 8
CR - Costa Rica 8
DZ - Algeria 8
ET - Etiopia 8
JM - Giamaica 8
NZ - Nuova Zelanda 8
PA - Panama 8
HU - Ungheria 7
KR - Corea 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
LT - Lituania 6
NP - Nepal 6
AM - Armenia 5
CH - Svizzera 5
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
HN - Honduras 5
KG - Kirghizistan 5
MD - Moldavia 5
PT - Portogallo 5
QA - Qatar 5
RS - Serbia 5
TT - Trinidad e Tobago 5
EE - Estonia 4
GR - Grecia 4
LV - Lettonia 4
NI - Nicaragua 4
OM - Oman 4
BA - Bosnia-Erzegovina 3
DK - Danimarca 3
GE - Georgia 3
KW - Kuwait 3
LB - Libano 3
AO - Angola 2
BG - Bulgaria 2
BY - Bielorussia 2
CY - Cipro 2
EU - Europa 2
GT - Guatemala 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
NC - Nuova Caledonia 2
PS - Palestinian Territory 2
Totale 24.976
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.327
Dublin 1.181
Chandler 1.053
Nanjing 1.001
San Jose 989
Singapore 790
Ashburn 765
Hong Kong 742
Dallas 732
Boardman 430
Nanchang 421
Beijing 355
Council Bluffs 321
Shenyang 300
Princeton 285
Hebei 283
Lawrence 275
Medford 267
Lauterbourg 266
Changsha 257
Wilmington 254
Los Angeles 227
Jiaxing 221
Ho Chi Minh City 215
Munich 174
Hangzhou 171
Helsinki 156
Tianjin 149
Hanoi 140
Johannesburg 136
Redondo Beach 123
Buffalo 121
Moscow 93
New York 92
São Paulo 89
Santa Clara 87
Toronto 77
Shanghai 60
Cambridge 56
Milan 55
Ann Arbor 53
Seattle 52
Woodbridge 49
Tokyo 47
Orem 38
San Francisco 36
Fairfield 33
Montreal 33
Norwalk 33
Turku 31
Da Nang 29
Jinan 29
Des Moines 27
Rio de Janeiro 27
Brooklyn 26
Tashkent 26
Atlanta 25
Baghdad 25
Chennai 25
Frankfurt am Main 25
Quito 25
Phoenix 24
Guangzhou 23
Haiphong 23
Kunming 23
Chicago 22
Zhengzhou 21
Boston 19
Bruino 19
Denver 19
Dhaka 19
London 19
Pavia 19
Stockholm 19
Belo Horizonte 18
Campinas 18
Columbus 18
Amman 17
Genova 17
Pune 17
Rome 17
The Dalles 17
Curitiba 15
Guayaquil 15
Ankara 14
Lima 14
Warsaw 14
Bogotá 13
Bologna 13
Falkenstein 13
Ningbo 13
Orange 13
Piscataway 13
Salvador 13
Charlotte 12
Hải Dương 12
Lahore 12
Mexico City 12
Biên Hòa 11
Houston 11
Totale 16.071
Salva come PNG Salva come JPEG
Nome #
Safety and efficacy of alpha lipoic acid during 4 years of observation: A retrospective, clinical trial in healthy subjects in primary prevention 313
Evaluation of the Effect on Sexual Performance of a Nutraceutical Combination Containing Alpha Lipoic Acid, Vitis vinifera L. and Ginkgo biloba, Compared to Placebo, Avanafil or a Combination of Nutraceutical Plus Avanafil in Males With Type 2 Diabetes Mellitus With Erectile Dysfunction 305
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 245
A randomized, placebo-controlled study about the effect of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters 205
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 189
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 159
A multicenter, randomised, single-blind study on the effects of exenatide or glimepiride on insulin resistance. 155
An evaluation of a nutraceutical with berberine, curcumin, inositol, banaba and chromium picolinate in patients with fasting dysglycemia 147
A comparison between sitagliptin or glibenclamide in addition to metformin+pioglitazone on glycemic control and beta-cell function: the triple oral therapy 145
Abscisic Acid Treatment in Patients with Prediabetes. 144
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 140
Effetti sulla variabilità glicemica e sul compenso glico-metabolico di metformina, pioglitazone e sitagliptin in pazienti affetti da diabete mellito di tipo 2 138
Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial 135
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 133
Adipocytokines levels in obese and non-obese subjects, an observational study 133
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 132
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus 132
A systematic reviewandmeta-analysis of randomized controlled trials investigating the effects of supplementationwith Nigella sativa (black seed) on blood pressure 131
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 130
Diagnostico y Tratamiento de los desordenes lipidicos. Mc Graw Hill Education 2014. 129
A randomized, double blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetic patients already treated with pioglitazone and metformin: a three years study 128
A randomized, double blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function. 127
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 127
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients 126
Diarrea in paziente diabetico 125
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 124
Confronto tra candesartan e olmesartan sui parametri correlati alla sensibilità insulinica nei pazienti ipertesi con diabete mellito di tipo 2 124
A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients 124
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 122
Effects of berberis aristata/silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients 121
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 118
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 115
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 114
A curious case of hypoglycaemia 114
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients 113
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 112
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 112
n-3 PUFAs on metalloproteinases, inflammatory and insulin resistance parameters in dyslipidemic patients after euglycemic clamp and oral fat load. 112
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 111
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 110
Comparison between exenatide and glimepiride on metabolic control and on insulin resistance in type 2 diabetic patients with metformin therapy 110
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 109
Effects of sibutramine plus L-carnitine compared to sibutramine on inflammatory parameters in type 2 diabetic patients 108
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 108
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici 107
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 106
Berberis aristata/silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients 105
Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis 103
Effects of berberine on lipid profile in subjects with low cardiovascular risk 102
Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate tea. 102
Effects of a combination of Berberis aristata, Silybum marianum and monacolin on lipid profile in subjects at low cardiovascular risk; a double-blind, randomized, placebo-controlled trial 101
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici di tipo 2 100
Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients 100
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin 99
Effects of thiazolidinediones and sulfonylureas in patients with diabetes 99
Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus 99
Sitagliptin added to previously taken anti-diabetic agents on insulin resistance and lipid profile: a two years study evaluation 98
Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy 97
Effect of manidipine-rosuvastatin combination on fibrinolysis, inflammation markers and insulin sensitivity in hypertensive hypercholesterolemic patients 96
Prevalence of erectile dysfunction in males affected by type 2 diabetes and the impact of hyperinsulinemia 95
Aerobic physical activity in obese subjects compared to anaerobic/aerobic physical activity 95
Berberis aristata/Silybum marianum fixed combination (Berberol®) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial. 95
Canrenone on cardiovascular mortality in congestive heart failure: CanrenOne eFFects on cardiovascular mortality in patiEnts with congEstIve hearT failure: The COFFEE-IT study 94
Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients 94
Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study 94
Candesartan effect on inflammation in hypertension 94
Prevalence and associations of erectile dysfunction in a sample of italian males with type 2 diabetes. 94
A role for quercetin in coronavirus disease 2019 (COVID-19) 93
Effetti di un carico lipidico orale sui marcatori di rimodellamento vascolare nei soggetti sani 93
Valutazione dei livelli di metalloproteasi 2 e 9 e dei loro inibitori nei soggetti con dislipidemia combinata 93
Effetto del telmisartan sui marcatori infiammatori a digiuno e postprandiale nei pazienti diabetici ipertesi 93
Current and emerging pharmacotherapies for the management of hypertension, focus on aliskiren 93
A randomized, double-blind, placebo-controlled study to evaluate the effectiveness of a food supplement containing creatine and d-ribose combined with a physical exercise program in increasing stress tolerance in patients with ischemic heart disease 92
Sitagliptin added to previously taken anti-diabetic agents on insulin resistance and lipid profile: a two years study evaluation. 92
Hypoglycemia, its implications in the clinical practice, and possible ways to prevent it. 92
Matrix metalloproteinase-2 and – 9 levels in obese patients 91
Anti-obesity drugs: a review about their effects and their safety 91
Effect of aliskiren addition to losartan on fibrinolysis in diabetic hypertensive patients: a three-way crossover study. 91
Vildagliptin added to metformin on β-cell function after an euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetic patients. 91
Sitagliptin in aggiunta alla precedente terapia ipoglicemizzante sull'insulino-resistenza e il profilo lipidico: uno studio a due anni 91
Effetti di un anno di trattamento con exenatide paragonato a glibenclamide in pazienti diabetici di tipo 2 91
Ascophyllum nodosum and Fucus vesiculosus on glycemic status and on endothelial damage markers in dysglicemic patients 91
Evaluation of candesartan compared to olmesartan on insulin sensitivity-related parameters in type 2 diabetic hypertensive patients 90
Rosiglitazone maleate and glimepiride in fixed combination for the metabolic control of type 2 diabetes 90
Valutazione dell’infiammazione e delle MMPs nei soggetti con e senza diabete durante OGTT 90
Comparison of orlistat treatment and placebo in obese type 2 diabetic patients 89
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia during omega-3 polyunsaturated fatty acids therapy 89
Metformina in bustine rispetto a metformina nella classica formulazione in compresse: primi risultati di uno studio clinico 89
Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study 89
Metformin powder formulation compared to metformin tablets on glycemic control and on treatment satisfaction in subjects with type 2 diabetes mellitus. 89
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus 89
Thiazolidinediones plus metformin association on body weight in patients with type 2 diabetes 88
Impact of the glyco-metabolic control on erectile dysfunction in patients with type 2 diabetes mellitus 87
Treatment options for hypercholesterolemia and combined dyslipidemia: focus on pitavastatin 87
Effetti di un carico lipidico orale sui marcatori di infiammazione e stress endoteliale nei soggetti sani 87
Pharmacotherapy for Obesity 87
Effetti di sitagliptin o metformina associati a pioglitazone in pazienti diabetici scarsamente controllati 87
Berberine induced improvement in hepatic steatosis index in overweight dyslipidaemic patients treated with lipid-lowering nutraceuticals 87
Effects on oral fat load of a nutraceutical combination of fermented red rice, sterol esters and stanols, curcumin, and olive polyphenols: A randomized, placebo controlled trial 87
Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients 86
Totale 11.388
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.751
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.022 0 4 65 9 4 6 8 58 59 7 175 627
2022/20233.250 358 193 6 221 372 348 2 198 1.370 40 94 48
2023/20241.058 120 196 37 73 121 257 16 120 9 33 37 39
2024/20253.371 24 329 98 110 70 89 246 284 718 77 368 958
2025/20267.977 552 588 1.066 1.006 817 310 1.495 343 647 556 405 192
2026/20271.226 537 689 0 0 0 0 0 0 0 0 0 0
Totale 25.360